{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:43:12Z","timestamp":1792633392783,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ymthe.2024.11.033","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T18:27:43Z","timestamp":1732645663000},"page":"235-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Bryce D.","family":"Holt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Druzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-2557","authenticated-orcid":false,"given":"Bartholomew A.","family":"Pederson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.11.033_bib1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1080\/15548627.2021.1969633","article-title":"Regulation and role of glycophagy in skeletal muscle energy metabolism","volume":"18","author":"Heden","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2024.11.033_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe Disease: From Basic Science to Therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2024.11.033_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2024.11.033_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2024.11.033_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-010-9206-3","article-title":"Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience","volume":"33","author":"Chakrapani","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.11.033_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/eci.12.40","article-title":"Immune modulation in Pompe disease treated with enzyme replacement therapy","volume":"8","author":"Banugaria","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.033_bib7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/WCO.0000000000001187","article-title":"Current avenues of gene therapy in Pompe disease","volume":"36","author":"Leon-Astudillo","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymthe.2024.11.033_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jimd.12560","article-title":"Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism","volume":"46","author":"Canibano-Fraile","year":"2023","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.11.033_bib9","article-title":"Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease","volume":"8","author":"Taylor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.11.033_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf1691","article-title":"Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders","volume":"16","author":"Ullman","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.11.033_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/hmg\/ddp535","article-title":"Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease","volume":"19","author":"Douillard-Guilloux","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.11.033_bib12","article-title":"Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease","author":"Weiss","year":"2024","journal-title":"bioRxiv."},{"key":"10.1016\/j.ymthe.2024.11.033_bib13","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ymthe.2021.02.015","article-title":"Centyrin ligands for extrahepatic delivery of siRNA","volume":"29","author":"Klein","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.11.033_bib14","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.11.033_bib15","article-title":"Targeting Transferrin Receptor to Transport Antisense Oligonucleotides Across the Blood-Brain Barrier","author":"Barker","year":"2023","journal-title":"biorxiv"},{"key":"10.1016\/j.ymthe.2024.11.033_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.medj.2022.09.007","article-title":"Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis","volume":"3","author":"Edavettal","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.ymthe.2024.11.033_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.ymthe.2024.11.033_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.11.033_bib19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ab.2011.12.026","article-title":"Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse","volume":"421","author":"Fuller","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2024.11.033_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1750-1172-8-182","article-title":"Phenotypical variation within 22 families with Pompe disease","volume":"8","author":"Wens","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2024.11.033_bib21","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1007\/s12035-017-0763-4","article-title":"A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2024.11.033_bib22","doi-asserted-by":"crossref","first-page":"17260","DOI":"10.1074\/jbc.M410448200","article-title":"Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise","volume":"280","author":"Pederson","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.11.033_bib23","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.2337\/diabetes.54.12.3466","article-title":"Glucose metabolism in mice lacking muscle glycogen synthase","volume":"54","author":"Pederson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2024.11.033_bib24","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1128\/MCB.24.16.7179-7187.2004","article-title":"Abnormal cardiac development in the absence of heart glycogen","volume":"24","author":"Pederson","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2024.11.033_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.molmet.2016.01.004","article-title":"Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice","volume":"5","author":"Xirouchaki","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymthe.2024.11.033_bib26","doi-asserted-by":"crossref","first-page":"E524","DOI":"10.1152\/ajpendo.00175.2024","article-title":"Small molecule inhibition of glycogen synthase I reduces muscle glycogen content and improves biomarkers in a mouse model of Pompe disease","volume":"327","author":"Gaspar","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2024.11.033_bib27","article-title":"A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice","volume":"5","author":"Savage","year":"2008","journal-title":"Plos Med."},{"key":"10.1016\/j.ymthe.2024.11.033_bib28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1369\/jhc.7A7239.2007","article-title":"Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model","volume":"55","author":"Taksir","year":"2007","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.ymthe.2024.11.033_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jnr.22579","article-title":"Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia","volume":"89","author":"Canada","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ymthe.2024.11.033_bib30","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/MCB.21.8.2683-2694.2001","article-title":"Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G\/RGL","volume":"21","author":"Suzuki","year":"2001","journal-title":"Mol. Cell. Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624007603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624007603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:30:52Z","timestamp":1783020652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624007603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1525001624007603"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.033","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}